日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Incidence and prevalence of clinically detected smoldering multiple myeloma within the general population: a retrospective observational cohort study

普通人群中临床检测到的冒烟型多发性骨髓瘤的发病率和患病率：一项回顾性观察队列研究

期刊:Blood Cancer Journal
影响因子:11.6
doi:10.1038/s41408-025-01352-3
Wong, Adrian; Jimenez-Zepeda, Victor H; Rankin, Kathryn; Sandhu, Irwin; Chu, Michael; Delluc, Aurélien; Mian, Hira; Stakiw, Julie; Cipkar, Christopher; McCurdy, Arleigh; Patrick, Benjamin; Albert, Sarah; Henia, Meriem; Koo, Edward; Sapru, Hyra; McCudden, Christopher; Visram, Alissa
多发性骨髓瘤
骨髓瘤
发表日期：2025
文献求助 收藏

Disease Characteristics and Outcomes of 493 Young Myeloma Patients Treated With Modern Therapies: A Canadian Myeloma Research Group Database Study

493例接受现代疗法治疗的年轻多发性骨髓瘤患者的疾病特征和预后：一项基于加拿大骨髓瘤研究组数据库的研究

期刊:Cancer Medicine
影响因子:3.1
doi:10.1002/cam4.70332
Tanguay, Mégane; Roy, Jean; Su, Jiandong; Gul, Engin; Reece, Donna; Venner, Christopher P; White, Darrell; Chu, Michael P; Jimenez-Zepada, Victor H; Song, Kevin; Mccurdy, Arleigh; Mian, Hira; Sebag, Michael; Bergstrom, Debra; Stakiw, Julie; Reiman, Anthony; Kotb, Rami; Aslam, Muhammad; Kaedbey, Rayan; Louzada, Martha; LeBlanc, Richard
多发性骨髓瘤
骨髓瘤
发表日期：2024
文献求助 收藏

Long-term follow-up of outcomes including progression-free survival 2 in patients with transplant-ineligible multiple myeloma in the real-world practice: A multi-institutional report from the Canadian Myeloma Research Group (CMRG) database

真实世界实践中不适合移植的多发性骨髓瘤患者的长期随访结果（包括无进展生存期2）：来自加拿大骨髓瘤研究组（CMRG）数据库的多中心报告

期刊:eJHaem
影响因子:1.2
doi:10.1002/jha2.894
Kaedbey, Rayan; Reece, Donna; Venner, Christopher P; McCurdy, Arleigh; Su, Jiandong; Chu, Michael; Louzada, Martha; Jimenez-Zepeda, Victor H; Mian, Hira; Song, Kevin; Sebag, Michael; Stakiw, Julie; White, Darrell; Reiman, Anthony; Aslam, Muhammad; Kotb, Rami; Bergstrom, Debra; Gul, Engin; LeBlanc, Richard
多发性骨髓瘤
骨髓瘤
发表日期：2024
文献求助 收藏

Redefining attrition in multiple myeloma (MM): a Canadian Myeloma Research Group (CMRG) analysis

重新定义多发性骨髓瘤（MM）中的损耗：加拿大骨髓瘤研究组（CMRG）的一项分析

期刊:Blood Cancer Journal
影响因子:11.6
doi:10.1038/s41408-023-00883-x
McCurdy, Arleigh; Mian, Hira; LeBlanc, Richard; Jimenez-Zepeda, Victor H; Su, Jiandong; Masih-Khan, Esther; Visram, Alissa; Louzada, Martha; Song, Kevin; White, Darrell; Sebag, Michael; Stakiw, Julie; Reiman, Anthony; Aslam, Muhammad; Bergstrom, Debra; Kotb, Rami; Kaedbey, Rayan; Gul, Engin; Reece, Donna; Venner, Christopher P
多发性骨髓瘤
骨髓瘤
发表日期：2023
文献求助 收藏

Correction: Redefining attrition in multiple myeloma (MM): a Canadian Myeloma Research Group (CMRG) analysis

更正：重新定义多发性骨髓瘤 (MM) 中的损耗：加拿大骨髓瘤研究组 (CMRG) 分析

期刊:Blood Cancer Journal
影响因子:11.6
doi:10.1038/s41408-023-00888-6
McCurdy, Arleigh; Mian, Hira; LeBlanc, Richard; Jimenez-Zepeda, Victor H; Su, Jiandong; Masih-Khan, Esther; Visram, Alissa; Louzada, Martha; Song, Kevin; White, Darrell; Sebag, Michael; Stakiw, Julie; Reiman, Anthony; Aslam, Muhammad; Bergstrom, Debra; Kotb, Rami; Kaedbey, Rayan; Gul, Engin; Reece, Donna; Venner, Christopher P
多发性骨髓瘤
骨髓瘤
发表日期：2023
文献求助 收藏

Real-world results of autologous stem cell transplantation in newly diagnosed multiple myeloma: a report from the Canadian Myeloma Research Group database

自体干细胞移植治疗新诊断多发性骨髓瘤的真实世界结果：来自加拿大骨髓瘤研究组数据库的报告

期刊:Blood Cancer Journal
影响因子:11.6
doi:10.1038/s41408-023-00905-8
Côté, Julie; LeBlanc, Richard; Mian, Hira; Chu, Michael P; McCurdy, Arleigh; Masih-Khan, Esther; Su, Jiandong; Jimenez-Zepeda, Victor H; Song, Kevin; Louzada, Martha; White, Darrell; Sebag, Michael; Reiman, Anthony; Stakiw, Julie; Kotb, Rami; Bergstrom, Debra; Aslam, Muhammad; Kaedbey, Rayan; Venner, Christopher P; Gul, Engin; Reece, Donna
发育与干细胞
多发性骨髓瘤
骨髓瘤
干细胞
细胞生物学
发表日期：2023
文献求助 收藏

Real world data on outcomes of anti-CD38 antibody treated, including triple class refractory, patients with multiple myeloma: a multi-institutional report from the Canadian Myeloma Research Group (CMRG) Database

抗CD38抗体治疗多发性骨髓瘤（包括三线耐药患者）的真实世界疗效数据：来自加拿大骨髓瘤研究组（CMRG）数据库的多中心报告

期刊:Blood Cancer Journal
影响因子:11.6
doi:10.1038/s41408-023-00946-z
Visram, A; De La Torre, A; White, D; Su, J; Masih-Khan, E; Chu, M; Jimenez-Zepeda, V; McCurdy, A; LeBlanc, R; Song, K; Mian, H; Louzada, M; Sebag, M; Bergstrom, D; Stakiw, J; Reiman, A; Kotb, R; Aslam, M; Venner, C; Kaedbey, R; Gul, E; Reece, D
多发性骨髓瘤
CD3
CD38
骨髓瘤
发表日期：2023
文献求助 收藏

Real-world data on lenalidomide dosing and outcomes in patients newly diagnosed with multiple myeloma: Results from the Canadian Myeloma Research Group Database

关于来那度胺在初诊多发性骨髓瘤患者中的剂量和疗效的真实世界数据：来自加拿大骨髓瘤研究组数据库的结果

期刊:Cancer Medicine
影响因子:3.1
doi:10.1002/cam4.5245
Mian, Hira; LeBlanc, Richard; Louzada, Martha; Masih-Khan, Esther; McCurdy, Arleigh; Venner, Christopher P; Stakiw, Julie; Kardjadj, Moustafa; Jimenez-Zepeda, Victor H; Sebag, Michael; White, Darrell; Aslam, Muhammad; Song, Kevin; Reiman, Anthony; Kotb, Rami; Gul, Engin; Reece, Donna
多发性骨髓瘤
骨髓瘤
发表日期：2023
文献求助 收藏

Sequential Use of Carfilzomib and Pomalidomide in Relapsed Multiple Myeloma: A Report from the Canadian Myeloma Research Group (CMRG) Database

卡非佐米和泊马度胺序贯治疗复发性多发性骨髓瘤：来自加拿大骨髓瘤研究组（CMRG）数据库的报告

期刊:Current Oncology
影响因子:3.4
doi:10.3390/curroncol29030132
McCurdy, Arleigh; Venner, Christopher P; Masih-Khan, Esther; Louzada, Martha; LeBlanc, Richard; Sebag, Michael; Song, Kevin; Jimenez-Zepeda, Victor H; Kotb, Rami; Kardjadj, Moustafa; Mian, Hira; White, Darrell; Stakiw, Julie; Aslam, Muhammad; Reiman, Anthony; Gul, Engin; Reece, Donna
多发性骨髓瘤
骨髓瘤
发表日期：2022
文献求助 收藏

Efficacy of Daratumumab-Containing Regimens Among Patients With Multiple Myeloma Progressing on Lenalidomide Maintenance: Retrospective Analysis

达雷妥尤单抗联合治疗方案在接受来那度胺维持治疗后进展的多发性骨髓瘤患者中的疗效：回顾性分析

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2022.826342
Mian, Hira; Eisfeld, Christine; Venner, Christopher P; Masih-Khan, Esther; Kardjadj, Moustafa; Jimenez-Zepeda, Victor H; Khandanpour, Cyrus; Lenz, Georg; McCurdy, Arleigh; Sebag, Michael; Song, Kevin; LeBlanc, Richard; White, Darrell; Stakiw, Julie; Reiman, Anthony; Louzada, Martha; Aslam, Muhammad; Kotb, Rami; Gul, Engin; Reece, Donna
骨髓瘤
多发性骨髓瘤
发表日期：2022
文献求助 收藏